a strong trendP = 0.0703
Our data support this mechanism, as patients in the MAS group had a significantly higher percentage of CD8 + T cells ( P = 0.004), and an elevated CD8 + T-cell percentage showed a strong trend toward being a risk factor for MAS in the multivariate analysis ( P = 0.0703).